XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning of period (in shares) at Oct. 01, 2022   27,679,000        
Exercise of stock options and vesting of other share-based awards   49,000        
Treasury shares purchased (in shares)   (116,000)        
End of period (in shares) at Dec. 31, 2022   27,612,000        
Beginning of period at Oct. 01, 2022 $ 1,095,731 $ 541 $ 652,467 $ (1,093,483) $ 1,572,234 $ (36,028)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     5,683      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (4,091)      
Treasury shares purchased       (11,470)    
Net income 42,190       42,190  
Other comprehensive income 22,216         22,216
End of period at Dec. 31, 2022 $ 1,150,259 $ 541 654,059 (1,104,953) 1,614,424 (13,812)
Beginning of period (in shares) at Sep. 30, 2023 27,466,000 27,466,000        
Exercise of stock options and vesting of other share-based awards   38,000        
Treasury shares purchased (in shares)   0        
End of period (in shares) at Dec. 30, 2023 27,504,000 27,504,000        
Beginning of period at Sep. 30, 2023 $ 1,214,382 $ 543 661,270 (1,134,429) 1,711,328 (24,330)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     5,178      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (2,906)      
Treasury shares purchased       0    
Net income 29,215       29,215  
Other comprehensive income 20,886         20,886
End of period at Dec. 30, 2023 $ 1,266,755 $ 543 $ 663,542 $ (1,134,429) $ 1,740,543 $ (3,444)